Recent advances of oncolytic virus in cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances of oncolytic virus in cancer therapy

Published:2020-02-20 Issue:10 Volume:16 Page:2389-2402
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Mondal Moumita¹²,Guo Jingao²,He Ping¹,Zhou Dongming²

Affiliation:

1. Joint Center for Infection and Immunity, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China

2. Vaccine Research Center, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China

Funder

National Natural Science Foundation of China

Strategic Priority Research Program of CAS

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1723363

Reference144 articles.

1. Viruses for Tumor Therapy

2. History of Oncolytic Viruses: Genesis to Genetic Engineering

3. Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma

4. Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1

5. Activated MEK Suppresses Activation of PKR and Enables Efficient Replication and In Vivo Oncolysis by Δγ 1 34.5 Mutants of Herpes Simplex Virus 1

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of immunotherapy in non-small cell lung cancer: mechanisms, clinical applications, and future prospects;Asia-Pacific Journal of Oncology;2024-09-11

2. High-dose vitamin C as a metabolic treatment of cancer: a new dimension in the era of adjuvant and intensive therapy;Clinical and Translational Oncology;2024-09-11

3. Oncolytic vaccinia virus harboring CLEC2A gene enhances viral replication and antitumor efficacy;Molecular Therapy: Oncology;2024-09

4. Microbes in the tumor microenvironment: New additions to break the tumor immunotherapy dilemma;Microbiological Research;2024-08

5. Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy;Acta Pharmacologica Sinica;2024-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3